Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosa
Authors:
- 1 November 2019
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 63 (11)
Abstract
New drugs with novel mechanisms of resistance are desperately needed to address both community and nosocomial infections due to Gram-negative bacteria. One such potential target is LpxC, an essential enzyme that catalyzes the first committed step of lipid A biosynthesis. Achaogen conducted an extensive research campaign to discover novel LpxC inhibitors with activity against Pseudomonas aeruginosa .Keywords
Funding Information
- CARB-X (IDSEP 160030-01-02)
- The Military Medical Research and Development Program, Defense Health Program, Department of Defense (W81XWH122000040)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (HHSN272201500009C)
- DOD | Defense Threat Reduction Agency (HDTRA107C0079)
- Wellcome Trust (IDSEP 160030-01-02)
This publication has 20 references indexed in Scilit:
- Exploring the UDP pocket of LpxC through amino acid analogsBioorganic & Medicinal Chemistry Letters, 2013
- Mechanisms Decreasing In Vitro Susceptibility to the LpxC Inhibitor CHIR-090 in the Gram-Negative Pathogen Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2012
- Lipid A Modification Systems in Gram-Negative BacteriaAnnual Review of Biochemistry, 2007
- Molecular Validation of LpxC as an Antibacterial Drug Target in Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2006
- Mutations in PA2491 ( mexS ) Promote MexT-Dependent mexEF-oprN Expression and Multidrug Resistance in a Clinical Strain of Pseudomonas aeruginosaJournal of Bacteriology, 2005
- Potent, Novel in Vitro Inhibitors of thePseudomonasaeruginosaDeacetylase LpxCJournal of Medicinal Chemistry, 2002
- Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?Clinical Infectious Diseases, 2002
- Characterization of MexE–MexF–OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosaMolecular Microbiology, 1997
- Overexpression of the mexC–mexD–oprJ efflux operon in nfxB‐type multidrug‐resistant strains of Pseudomonas aeruginosaMolecular Microbiology, 1996
- Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1990